Last Update Time:
21-Mar-2025 10:57:17
ISIN:
INE04LG01015
Sector:
Healthcare
Symbol:
PAR
Par Drugs and Chemicals Limited
₹98.45
₹0.73
(0.75%)
▲
Prev. Close
₹97.72
Open
₹97.00
Close
₹0.00
Range
₹93.53 - ₹103.37
High
₹99.38
Low
₹96.00
Ind. Close
₹0.00
VWAP
₹98.13
The current stock price of Par Drugs and Chemicals Limited is ₹98.45, with a target price range between ₹93.53 and ₹103.37. The stock has experienced a price change of ₹0.73 (0.75%), reflecting recent market volatility.
Today's opening price was ₹97.00, while the previous close stood at ₹97.72.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Par Drugs and Chemicals Limited Price Chart
Par Drugs and Chemicals Limited Pre Open Market Overview: 21-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 97
- Previous Close Price: 97.72
- Change: -0.72%
- Total Traded Volume: 43
- Total Buy Quantity: 3,532
- Total Sell Quantity: 2,932
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 95.50 | 50.00 | 0.00 |
| 95.72 | 50.00 | 0.00 |
| 96.00 | 50.00 | 0.00 |
| 96.01 | 50.00 | 0.00 |
| 97.00 | 1.00 | 0.00 |
| 99.50 | 0.00 | 500.00 |
| 99.90 | 0.00 | 500.00 |
| 99.99 | 0.00 | 234.00 |
| 100.00 | 0.00 | 50.00 |
| 100.50 | 0.00 | 200.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 97.75 | 7 | 98.45 | 4 |
| 97.71 | 200 | 98.50 | 74 |
| 97.70 | 50 | 98.99 | 821 |
| 97.60 | 3 | 99.00 | 239 |
| 97.51 | 100 | 99.19 | 192 |
Total Buy Quantity: 3532
Total Sell Quantity: 2932
Shareholding Patterns of Par Drugs and Chemicals Limited
Key Trade Statistics of Par Drugs and Chemicals Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 0.08 |
| Traded Value (₹ Cr.) | 0.08 |
| Total Market Cap (₹ Cr.) | 121.14 |
| Free Float Market Cap (₹ Cr.) | 32.26 |
| Impact cost | 0.54 |
| Quantity Traded | N/A |
| Deliverable Quantity | N/A |
| % of Quantity to Traded | N/A |
| Security VaR | N/A |
| Index VaR | N/A |
| VaR Margin | 100 |
| Extreme Loss Rate | N/A |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 100 |
| Face Value | 10 |
Key Price Statistics of Par Drugs and Chemicals Limited
The 52-week high for Par Drugs and Chemicals Limited was ₹348.45, recorded on 02-Dec-2024. On the other hand, the 52-week low stands at ₹89.70, with the lowest value recorded on 05-Mar-2025.
The upper band for trading is ₹102.60, and the lower band is ₹92.83. The price band is 5%.
The stock's daily volatility stands at 3.70, while the annualized volatility is 70.69. The tick size for trading is ₹0.01.
| Price Information | Details |
|---|---|
| 52 Week High (02-Dec-2024) | 348.45 |
| 52 Week Low (05-Mar-2025) | 89.70 |
| Upper Band | 102.60 |
| Lower Band | 92.83 |
| Price Band (%) | 5 |
| Daily Volatility | 3.70 |
| Annualised Volatility | 70.69 |
| Tick Size | 0.01 |
Key Securities Statistics of Par Drugs and Chemicals Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 16-Sep-2021 |
| Adjusted P/E | 7.79 |
| Symbol P/E | 7.79 |
| Index | NA |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Basic Industry | Pharmaceuticals |
Security Status of Par Drugs and Chemicals Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Par Drugs and Chemicals Limited
| Subject | Date |
|---|---|
| Copy of Newspaper Publication | 15-Feb-2025 |
| Agreements,Contracts,Arrangements,MOU-XBRL | 14-Feb-2025 |
| Agreements | 14-Feb-2025 |
| Agreements | 14-Feb-2025 |
| Outcome of Board Meeting | 14-Feb-2025 |
| Updates | 14-Feb-2025 |
| Integrated Filing- Financial | 14-Feb-2025 |
| Outcome of Board Meeting | 14-Feb-2025 |
Corporate Actions of Par Drugs and Chemicals Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | Extra Ordinary General Meeting | 23-Dec-2024 |
| 10 | Annual General Meeting | 13-Sep-2024 |
| 10 | Annual General Meeting | 08-Sep-2023 |
| 10 | Annual General Meeting | 01-Sep-2022 |
| 10 | Interim Dividend - Rs 1.25 Per Share | 22-Nov-2021 |
Board Meetings of Par Drugs and Chemicals Limited
Financial Results of Par Drugs and Chemicals Limited
Company Directory of Par Drugs and Chemicals Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| N/A | Head Office/ Corporate Office | 816, Nilamber Triumph Gotri Vasna Road |
VADODARA |
| N/A | Head Office/ Corporate Office | 816, Nilamber Triumph Gotri Vasna Road |
VADODARA |
| N/A | Registered Office | 815, Nilamber Triumph Gotri Vasna Road |
VADODARA |
| N/A | Registered Office | 815, Nilamber Triumph Gotri Vasna Road |
VADODARA |
| N/A | Transfer Agent | C 101, 1st Floor, 247 Park, L.B.S. Marg, Vikhroli (West), Mumbai |
MUMBAI |
| N/A | Transfer Agent | C 101, 1st Floor, 247 Park, L.B.S. Marg, Vikhroli (West), Mumbai |
MUMBAI |
Insider Trading of Par Drugs and Chemicals Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | SARITABEN VALLABHBHAI SAVANI | 665575 | Sell |
| 7(2) | SARITABEN VALLABHBHAI SAVANI | 22421221 | Sell |
| 7(2) | SARITABEN VALLABHBHAI SAVANI | 0 | Buy |
| 7(2) | GHANSHAYAMBHAI BHAGVANBHAI SAVANI | 148449 | Buy |
| 7(2) | RITA HARESH RADADIYA | 37486 | Buy |
| 7(2) | JIGNESH VALLABHBHAI SAVANI | 138230 | Buy |
| 7(2) | VALLABHBHAI JIVABHAI SAVANI | 294370 | Buy |
| 7(2) | NAYNA JIGNESH SAVANI | 283027 | Buy |
| 7(2) | NAYNA JIGNESH SAVANI | 147434 | Buy |
| 7(2) | JIGNESH VALLABHBHAI SAVANI | 152619 | Buy |
| 7(2) | NAYNA JIGNESH SAVANI | 461657 | Buy |
| 7(2) | GHANSHAYAMBHAI BHAGVANBHAI SAVANI | 307992 | Buy |
| 7(2) | NAYNA JIGNESH SAVANI | 303760 | Buy |
| 7(2) | VALLABHBHAI JIVABHAI SAVANI | 150457 | Buy |
| 7(2) | SHILPA FALGUNBHAI SAVANI | 149911 | Buy |
| 7(2) | SHILPABEN FALGUN SAVANI | 149911 | Buy |
| 7(2) | JIGNESH VALLABHBHAI SAVANI | 150750 | Buy |
| 7(2) | VALLABHBHAI JIVABHAI SAVANI | 456401 | Buy |
| 7(2) | JIGNESH VALLABHBHAI SAVANI | 150750 | Buy |
| 7(2) | GHANSHAYAMBHAI BHAGVANBHAI SAVANI | 143000 | Buy |
Annual Reports of Par Drugs and Chemicals Limited
| Company | From Year | To Year | Att. |
|---|---|---|---|
| Par Drugs And Chemicals Limited | 2023 | 2024 | |
| Par Drugs And Chemicals Limited | 2022 | 2023 | |
| Par Drugs And Chemicals Limited | 2021 | 2022 |
Investor Complaints of Par Drugs and Chemicals Limited
Event Calendar of Par Drugs and Chemicals Limited
| Purpose | Details |
|---|---|
| Other business matters | Other business matters; 1. To authorize director of the Company to file Satisfaction of Charges 2.To authorize director of the company to file Satisfaction of Charges and to sign, file and affirm the petition and other related documents for condonation of delay 3.To appoint Internal Auditors of the Company 4.To appoint Secretarial Auditor of Company 5.To appoint GST auditor of the Company 6.To consider any other matter with the permission of the Chair |
| Other business matters | To consider other business matters |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended September 30, 2019, dividend and other business matters |
| Other business matters | To consider other business matters |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2020, dividend and other business matters |
| Other business matters | To consider other business matters |
| Other business matters | To consider other business matters |
| Other business matters | To consider other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2020 and other business matters |
| Other business matters | To consider other business matters |
| Bonus/Other business matters | To consider bonus and other business matters |
| Bonus/Other business matters | To consider bonus and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2021 and other business matters |
| Other business matters | To consider other business matters |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended September 30, 2021, dividend and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2021 and other business matters |
| Other business matters | Par Drugs And Chemicals Limited has informed the Exchange about Board Meeting to be held on 13-Jun-2022 to consider Other business matters |
| Other business matters | Par Drugs And Chemicals Limited has informed the Exchange about Board Meeting to be held on 28-Jul-2022 to consider Other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2022 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2023 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2023 and other business matters |
| Other business matters | To consider other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2023 and other business matters |
| Financial Results/Other business matters | PAR : 16-Feb-2024 : The Company has informed the Exchange that a Board meeting to be held on February 14, 2024 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on February 16, 2024, To consider and approve the financial results for the period ended December 31, 2023 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2023 and other business matters |
| Other business matters | To consider other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the quarter and year ended on March 31, 2024 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2024 and other business matters |
| Other business matters | To consider other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2024 and other business matters |
| Other business matters | To consider other business matters |
| Other business matters | To consider other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2024 and other business matters |
Share Transfers of Par Drugs and Chemicals Limited
Voting Results of Par Drugs and Chemicals Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 12-FEB-2025 | EGM | APPROVAL FOR SLUMP SALE OF THE EXISTING ESTABLISHMENT (LAND, BUILDING, PLANT & nMACHINERY, SPECIFIC CURRENT ASSETS & CURRENT LIABILITIES) WITH REVISED TERMS nUNDER SECTION 180(1)(A) OF THE COMPANIES ACT, 2013 AND REGULATION 37A OF nSECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE nREQUIREMENTS) REGULATIONS, 2015 |
| 12-FEB-2025 | EGM | TO MAKE VENTURE IN TO THE BUSINESS OF REAL-ESTATE AND CONSTRUCTION DIRECTLY OR nINDIRECTLY, CAPITAL MARKET DIRECTLY OR INDIRECTLY AND ENTER INTO THE BUSINESS OF nTHE CLEAN AND RENEWABLE ENERGY BY ALTERATION OF MAIN OBJECT CLAUSE OF THE nCOMPANY |
| 31-DEC-2024 | EGM | Approval For Slump Sale of The Existing Establishment (Land, Building, Plant & Machinery, Specific Current Assets & Current Liabilities) Under Section 180(1)(A) of The Companies Act, 2013 And Regulation 37a Of Securities and Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 |
| 31-DEC-2024 | EGM | To Make Venture in to The Business of Real-Estate and Construction Directly or Indirectly, Capital Market and Directly or Indirectly, Enter into The Business of The Clean and Renewable Energy by Alteration of Main Object of The Company |
| 21-SEP-2024 | AGM | To receive, consider and adopt the Audited Standalone Financial Statements of the company for the financial year ended on 31st March, 2024 together with the report of the Board of Directors and Auditors thereon. |
| 21-SEP-2024 | AGM | To fix remuneration payable to Mr. Pravin Manjibhai Bhayani (DIN: 08332851) as an Independent Director of the Company and if thought fit, to pass with or without modification(s) the Resolution as a Special Resolution |
| 21-SEP-2024 | AGM | To appoint statutory auditors of the Company and to fix their remuneration and in this regard to consider and if thought fit, to pass, with or without modification (s), the resolution as an Ordinary resolution. |
| 21-SEP-2024 | AGM | To appoint a Director in place of Mr. Ghanshyam Bhagvanbhai Savani, Whole-time Director (DIN: 03055941), who retires by rotation and being eligible offer himself for re-appointment. |
| 16-SEP-2023 | AGM | To receive, consider and adopt the Audited Standalone Financial Statements of the company fornthe financial year ended on 31st March, 2023 together with the report of the Board of Directors and Auditors thereon. |
| 16-SEP-2023 | AGM | To re-appoint Mr. Jignesh Vallabhbhai Savani (DIN: 00198203) as a CEO of the company and tonfix Remuneration payable to him and to consider and if thought fit, to pass with or without modification(s) the following Resolution as a Special Resolution |
| 16-SEP-2023 | AGM | To re-appoint Mr. Ghanshayambhai Bhagvanbhai Savani (DIN: 03055941) as a WholetimenDirector and to fix Remuneration payable to him and to consider and if thought fit, to pass with or without modification(s) the following Resolution as a Special Resolution |
| 16-SEP-2023 | AGM | To re-appoint Mr. Falgun Vallabhbhai Savani (DIN: 00198236) as Chairman & Managing Director ofn the company and fix Remuneration payable to him and to consider and if thought fit, to pass with or without modification(s) the following Resolution as a Special Resolution |
| 16-SEP-2023 | AGM | To re-appoint Mrs. Kajal Chintanbhai Vaghani (DIN: 08317641) as an Independent Director of thenCompany and if thought fit, to pass with or without modification(s) the following Resolution as a Special Resolution |
| 16-SEP-2023 | AGM | To re-appoint Mrs. Krishna Mitulbhai Shah (DIN: 08317678) as an Independent Director of the Company and if thought fit, to pass with or without modification(s) the following Resolution as a Special Resolution |
| 16-SEP-2023 | AGM | To re-appoint Mr. Pravin Manjibhai Bhayani (DIN: 08332851) as an Independent Director of thenCompany and to fix remuneration payable to him and if thought fit, to pass with or without modification(s) the following Resolution as a Special Resolution |
| 16-SEP-2023 | AGM | To appoint statutory auditors of the Company and to fix their remuneration and in this regardnto consider and if thought fit, to pass, with or without modification (s), the following resolution as an Ordinary resolution |
| 16-SEP-2023 | AGM | To appoint a Director in place of Mr. Jignesh Vallabhbhai Savani, Director & CEO (DIN: 00198203),nwho retires by rotation and being eligible offer himself for re-appointment. |
| 10-SEP-2022 | AGM | To receive, consider and adopt the Audited Standalone Financial Statements of the Companynfor the financial year ended on 31st March, 2022 together with the report of the Board ofnDirectors and Auditor thereon |
| 10-SEP-2022 | AGM | To appoint statutory auditors of the Company and to fix their remuneration and in thisnregard to consider and if thought fit, to pass, with or without modification (s). |
| 10-SEP-2022 | AGM | To appoint a Director in place of Mr. Falgun Vallabhbhai Savani, Chairman & ManagingnDirector (DIN: 00198236), who retires by rotation and being eligible offer himself for reappointment. |
FAQs on Par Drugs and Chemicals Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.